NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pivotal bioVenture Partners China

Pivotal bioVenture Partners China

Shanghai, Shanghaipivotalbiovp.com

Overview

Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences, is a venture capital firm specializing in venture building in the life sciences industry. Its investment strategy is centered on identifying promising innovative products and technologies and bringing them to serve the growing unmet medical needs in Greater China region by building new ventures. Its investment areas include therapeutics, medical devices and medical services. The Pivotal China team includes experienced life science investors and entrepreneurs with successful track records of venture building and investing.

Year Founded

2017

Portfolio Companies

10

Investments

Pivotal bioVenture Partners China investments
CompanyDateStageLead
HerAnova LifesciencesDec 2023SeedCo-investor
PlexiumFeb 2022Series BCo-investor
Arkuda TherapeuticsFeb 2022Series BLead
Ablaze PharmaceuticalsNov 2021Series ACo-investor
Arctic VisionMar 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.